MAPT and Alzheimer disease: From our analysis included in Table 2, it can be observed that the baseline CSF Aβ1-42 concentrations for these 15 patients were closer to the values for progressive MCI (MCI_AD) at the early follow-up, and for P-tau they were closer to non-progressive MCI (stable MCI).